Literature DB >> 9887201

Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages.

C A Louis1, V Mody, W L Henry, J S Reichner, J E Albina.   

Abstract

Macrophages can express two arginase isoforms with distinct subcellular localization (cytosolic AI and mitochondrial AII). These isoforms are products of different genes and are capable of differential induction. Experiments were performed to identify the specific arginase isoforms induced by interleukin (IL)-4, a Th2 cytokine shown by others to increase arginase activity in macrophages, and serum. Results indicate IL-4, in concert with serum, increases AI, but not AII, mRNA in cultured murine macrophages. Moreover, they show serum to induce both arginase isoforms and to be required for maximal AI induction by IL-4. Together with the enhanced expression of AI, IL-4 induced the expression of the cationic amino acid transporter MCAT-2 and increased L-arginine transport into the cells. Present results confirm, then, specificity in the ability of macrophage arginase isoforms to be induced by different stimuli. Moreover, they suggest that a decrease in intracellular L-arginine concentration resulting from its consumption by arginase may be repaired by concurrent increases in L-arginine influx into the cell.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9887201     DOI: 10.1152/ajpregu.1999.276.1.R237

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  27 in total

1.  Editorial: Orchestration of macrophage polarization by polyamines.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  J Leukoc Biol       Date:  2012-05       Impact factor: 4.962

2.  Autacoid 14S,21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions.

Authors:  Haibin Tian; Yan Lu; Shraddha P Shah; Song Hong
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

Review 3.  Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy.

Authors:  Meera G Nair; Katherine J Guild; David Artis
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 4.  Macrophage phenotypes during tissue repair.

Authors:  Margaret L Novak; Timothy J Koh
Journal:  J Leukoc Biol       Date:  2013-03-15       Impact factor: 4.962

5.  Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I.

Authors:  Eric Riley; Sigrid C Roberts; Buddy Ullman
Journal:  Int J Parasitol       Date:  2011-01-11       Impact factor: 3.981

6.  Macrophage activation and skeletal muscle healing following traumatic injury.

Authors:  Margaret L Novak; Eileen M Weinheimer-Haus; Timothy J Koh
Journal:  J Pathol       Date:  2014-02       Impact factor: 7.996

7.  Hypoxia in Leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages.

Authors:  Alexander Mahnke; Robert J Meier; Valentin Schatz; Julian Hofmann; Kirstin Castiglione; Ulrike Schleicher; Otto S Wolfbeis; Christian Bogdan; Jonathan Jantsch
Journal:  J Invest Dermatol       Date:  2014-02-28       Impact factor: 8.551

Review 8.  Arginase: an emerging key player in the mammalian immune system.

Authors:  Markus Munder
Journal:  Br J Pharmacol       Date:  2009-09-17       Impact factor: 8.739

9.  Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation.

Authors:  Zili Zhai; Avery Solco; Lankun Wu; Eve S Wurtele; Marian L Kohut; Patricia A Murphy; Joan E Cunnick
Journal:  J Ethnopharmacol       Date:  2008-12-07       Impact factor: 4.360

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.